Multi-strain probiotic supplementation with L. acidophilus, B. longum, and B. bifidum has shown promise in slowing CKD progression through anti-inflammatory mechanisms, though its effect on uremic toxins remains unconfirmed.
Mechanism#
Restores commensal populations depleted by the uremic milieu. Reduces bacterial translocation and endotoxemia by improving gut barrier integrity. Decreases systemic inflammatory markers (IL-6, IL-18, TNF-alpha) that drive renal fibrosis.
Clinical Evidence#
eGFR preservation: Decline slowed from -0.54 to 0.00 ml/min/month in the supplemented group. Endotoxin reduction: Significant decrease in circulating endotoxin levels. Inflammatory markers: IL-6, IL-18, and TNF-alpha all decreased.
Important Limitation#
A meta-analysis of 21 RCTs found that probiotics did NOT significantly reduce indoxyl sulfate or p-cresyl sulfate levels. The renal benefit may operate through anti-inflammatory pathways rather than uremic toxin reduction.
Cross-References#
Article network
Mentioned here 3
Pages linking here 2
Connect the evidence
Publicly readable discussion by ORCID-authenticated researchers. Questions, interpretation, methods, corrections, and new evidence stay attached to this record.
No discussion yet. Start with a precise question or a source-backed observation.
Activity and accepted changes
Accepted researcher context, editorial status, public discussion, and upstream Git revisions are shown together. Pending, declined, and withdrawn proposals remain private.
- published revision
Deepen metal/concept entities + 8 new sources for T1D/schizophrenia
WikiBiome Deploy Bot · +56 −0
Inspect exact Git diff ↗